| Followers | 192 |
| Posts | 11943 |
| Boards Moderated | 1 |
| Alias Born | 11/29/2007 |
Friday, June 26, 2020 3:16:03 PM
GRN Holding Corporation (GRNF) Announces That Sunshine Hemp has Received First Hemp Seed Approval in State of Florida
Friday, June 26, 2020 3:15 PM EST
SEATTLE, WA / ACCESSWIRE / June 26, 2020 / GRN Holding Corporation (OTC PINK:GRNF) (the "Company"), is pleased to announce that Sunshine Hemp, Inc. ("Sunshine"), the first permitted University Hemp research program in Florida, received the first approval in the State for "Pilot Project Hemp Seeds" which allows Sunshine the opportunity to legally sell those hemp seeds to a potential market of approximately 1,200 applicants who applied for cultivation licenses in Florida's new State Hemp Program. Sunshine Hemp will be the only University approved company with tested strains of premium CBD and CBG dominant feminized hemp seeds, seedlings, and cultivars for sale to Florida growers.
In 2018, Sunshine Hemp partnered with Florida A&M University in the Florida Industrial Hemp Research Pilot Program authorized under Section 1004.4473, F.S to research, test and commercialize hemp genetics that would perform well in Florida and meet all state and federal compliance guidelines.
After a rigorous 12-week research program with extensive data analysis and testing at the Sunshine Hemp research sites in Florida, the University approved the seeds as the first "Pilot Project Hemp Seeds & Cultivars" under the stringent guidelines dictated by Florida law and the Florida Department of Agriculture and Consumer Services. This allows Sunshine Hemp to market and sell seeds, seedlings, and cultivars to hemp growers in Florida as well as outside the state.
The approval positions Sunshine Hemp to be first to market with legal hemp seeds, seedlings, and cultivars. Under Florida law s. 581.217, F.S. all hemp growers are required to use hemp seeds that are either University approved "Pilot Project Hemp Seeds and Cultivars" or hemp seeds certified by the Association of Seed Certifying Agencies (AOSCA). The strict hemp genetics requirements were enacted in law to ensure that Florida hemp growers would use seeds certified as high quality, stable, consistent, and compliant with federal and state requirements. All hemp growers are required to use a certified seed.
In 2019, Sunshine Hemp, Inc. entered into a binding LOI with the Company to become part of the family of GRN Holding businesses. The Company and Sunshine are pending completion of the transaction. The approval of Sunshine Hemp seeds makes Sunshine the leading hemp seed provider in the state. Sunshine plans to launch a major hemp breeding program over the course of the next 6 months.
Sunshine partner and GRN Advisory Board member, Dr. Jeffrey Sharkey, said "We are truly excited about Sunshine Hemp's genetic research efforts and receiving the first University approval in the state for "Pilot Project Hemp Seeds". Once growers heard we were the only program with state approved hemp seeds, we have received dozens and dozens of inquiries to purchase seeds, seedlings and cultivars."
Friday, June 26, 2020 3:15 PM EST
SEATTLE, WA / ACCESSWIRE / June 26, 2020 / GRN Holding Corporation (OTC PINK:GRNF) (the "Company"), is pleased to announce that Sunshine Hemp, Inc. ("Sunshine"), the first permitted University Hemp research program in Florida, received the first approval in the State for "Pilot Project Hemp Seeds" which allows Sunshine the opportunity to legally sell those hemp seeds to a potential market of approximately 1,200 applicants who applied for cultivation licenses in Florida's new State Hemp Program. Sunshine Hemp will be the only University approved company with tested strains of premium CBD and CBG dominant feminized hemp seeds, seedlings, and cultivars for sale to Florida growers.
In 2018, Sunshine Hemp partnered with Florida A&M University in the Florida Industrial Hemp Research Pilot Program authorized under Section 1004.4473, F.S to research, test and commercialize hemp genetics that would perform well in Florida and meet all state and federal compliance guidelines.
After a rigorous 12-week research program with extensive data analysis and testing at the Sunshine Hemp research sites in Florida, the University approved the seeds as the first "Pilot Project Hemp Seeds & Cultivars" under the stringent guidelines dictated by Florida law and the Florida Department of Agriculture and Consumer Services. This allows Sunshine Hemp to market and sell seeds, seedlings, and cultivars to hemp growers in Florida as well as outside the state.
The approval positions Sunshine Hemp to be first to market with legal hemp seeds, seedlings, and cultivars. Under Florida law s. 581.217, F.S. all hemp growers are required to use hemp seeds that are either University approved "Pilot Project Hemp Seeds and Cultivars" or hemp seeds certified by the Association of Seed Certifying Agencies (AOSCA). The strict hemp genetics requirements were enacted in law to ensure that Florida hemp growers would use seeds certified as high quality, stable, consistent, and compliant with federal and state requirements. All hemp growers are required to use a certified seed.
In 2019, Sunshine Hemp, Inc. entered into a binding LOI with the Company to become part of the family of GRN Holding businesses. The Company and Sunshine are pending completion of the transaction. The approval of Sunshine Hemp seeds makes Sunshine the leading hemp seed provider in the state. Sunshine plans to launch a major hemp breeding program over the course of the next 6 months.
Sunshine partner and GRN Advisory Board member, Dr. Jeffrey Sharkey, said "We are truly excited about Sunshine Hemp's genetic research efforts and receiving the first University approval in the state for "Pilot Project Hemp Seeds". Once growers heard we were the only program with state approved hemp seeds, we have received dozens and dozens of inquiries to purchase seeds, seedlings and cultivars."
Recent MAJI News
- NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist • GlobeNewswire Inc. • 05/11/2026 03:53:17 PM
- NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test • GlobeNewswire Inc. • 04/07/2026 02:30:00 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/30/2026 04:15:02 AM
- Form 253G1 - • Edgar (US Regulatory) • 03/27/2026 07:12:08 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/26/2026 08:25:15 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/20/2026 08:23:33 PM
- Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value • GlobeNewswire Inc. • 03/16/2026 02:15:00 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/11/2026 07:11:39 PM
- Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions • GlobeNewswire Inc. • 03/05/2026 06:00:20 PM
- Form 1-A POS - • Edgar (US Regulatory) • 02/19/2026 09:39:04 PM
- Form 253G2 - • Edgar (US Regulatory) • 02/11/2026 08:06:08 PM
- Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition • GlobeNewswire Inc. • 02/10/2026 03:30:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 01/15/2026 06:47:01 PM
- Form 253G1 - • Edgar (US Regulatory) • 01/14/2026 09:54:45 PM
- Form 1-A POS - • Edgar (US Regulatory) • 12/31/2025 12:32:47 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/29/2025 08:29:49 PM
- Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization • ACCESS Newswire • 12/11/2025 05:15:00 PM
- Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement • ACCESS Newswire • 12/05/2025 04:00:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/04/2025 09:35:28 PM
- Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms • ACCESS Newswire • 12/02/2025 06:45:00 PM
- Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value • ACCESS Newswire • 11/17/2025 08:40:00 PM
- Exousia Pro Announces Breakthrough In Exosome-Based Delivery • ACCESS Newswire • 11/04/2025 03:40:00 PM
- Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA • ACCESS Newswire • 10/28/2025 02:20:00 PM
- Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes • ACCESS Newswire • 09/29/2025 04:35:00 PM
